Published through 2026-11-02 23:51 UTC · Automated cloud publishing.
ZEISS Launches MyoActive Lens in Canada Following Vancouver Summit
Understand the event
On October 4, ZEISS hosted its Myopia Innovation Summit at the JW Marriott Parq Vancouver, introducing the ZEISS MyoActive spectacle lens for children. The initial reporting highlighted that this product utilizes MOVE technology to address myopia progression in young patients, serving as a platform for industry experts to discuss new optical solutions. While early coverage confirmed the launch event and the core technical designation of MOVE technology, it did not elaborate on clinical efficacy data or specific expert commentary regarding the underlying mechanisms. Subsequent reporting from Optical Prism on October 23 clarified the commercial availability of the MyoActive lens within the Canadian market. This later update introduced a distinct technical description, characterizing the MyoActive lens as the first myopia management product to apply Dynamic Signal Theory. It is important to note the discrepancy between the earlier report’s emphasis on "MOVE technology" and the newer report’s attribution of "Dynamic Signal Theory." The provided sources do not explicitly reconcile these terms, leaving uncertainty as to whether they refer to the same proprietary mechanism under different names or represent conflicting technical descriptions. The chronological development confirms the transition from a regional professional introduction in Vancouver to broader market availability in Canada, with evolving technical narratives surrounding the product's operational principles.
AI-generated from reporting · updated 10 days ago
Developments
- 10-23 21:00 · 1 reportsZEISS introduces MyoActive in CanadaOptical Prism：ZEISS introduces MyoActive myopia management lens in Canada
- 10-16 20:34 · 1 reportsZEISS introduces MyoActive myopia lens at Vancouver summitOptikNow：ZEISS Hosts Myopia Innovation Summit in Vancouver Introducing MyoActive Lens
Reporting timeline
Follow the reporting for different perspectives.
- Optical PrismZEISS introduces MyoActive myopia management lens in Canada
ZEISS has introduced its MyoActive lens in Canada. The product is described as the first myopia management lens to apply Dynamic Signal Theory. This announcement marks the availability of the specific technology within the Canadian market.
- OptikNowZEISS Hosts Myopia Innovation Summit in Vancouver Introducing MyoActive Lens
ZEISS convened eye care professionals at the JW Marriott Parq Vancouver on October 4 for its Myopia Innovation Summit. The event introduced ZEISS MyoActive, a spectacle lens for children utilizing MOVE technology. Clinical data from an ongoing two-year randomized controlled trial (NCT06563700) in Shanghai indicated that MyoActive delivered an average efficacy of 0.60 D less spherical equivalent refractive error progression compared to single-vision lenses over twelve months, with 98% of children adapting within one week. Sessions featured presentations by Professor Padmaja Sankaridurg, Dr. Debbie Jones, Dr. Wes McCann, and Dr. Evelyn Lo, covering scientific evidence, measurement importance, glaucoma assessment, and practice management. Hands-on demonstrations linked diagnostics to patient communication. The summit series continues in Montréal on October 17 and Toronto on October 25.